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Antiviral proteins encoded by the interferon (IFN)-stimulated genes provide a front-line defense against viral infections. In
particular, PKR, RNase L, and Mx are considered to be the principal proteins through which IFNs mount an antiviral state. To
determine whether alternative antiviral pathways exist, RNase L2/2 mice and PKR2/2 mice were crossed onto an Mx12/2
background to generate a strain of triply deficient (TD) mice. After infections with encephalomyocarditis virus, the TD mice
died 3–4 days earlier than infected, wild-type mice. However, there was an IFN dose-dependent increase in survival times
after encephalomyocarditis virus infections for both the TD and wild-type mice. Mice that were deficient for PKR or RNase
L showed intermediate survival times between those of the TD and wild-type mice. Surprisingly, cultured embryonic
fibroblasts lacking RNase L, PKR, or both proteins were still able to mount a substantial residual antiviral response against
encephalomyocarditis virus or vesicular stomatitis virus after IFN-a treatments. These results confirm the antiviral functions
of RNase L and PKR in vivo but also provide unequivocal evidence for the existence of novel, innate immune pathways against
viruses. © 1999 Academic Press
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IINTRODUCTION
The interferons (IFNs) are a family of cytokines that
hare the ability to produce an antiviral state in cells by
nducing expression of IFN-stimulated genes (ISGs)
Stark et al., 1998). Investigations into the molecular
echanisms of IFN action have focused on three IFN-
egulated pathways: the 2-5A/RNase L system, protein
inase PKR, and the Mx proteins. The 2-5A system is a
egulated RNA decay pathway in which IFN-induced and
sRNA-dependent 2-5A synthetases produce 29,59-oli-
oadenylates (2-5A) that activate RNase L (Kerr and
rown, 1978; Clemens and Williams, 1978; Slattery et al.,
979; Zhou et al., 1993). PKR is an IFN-induced, dsRNA-
ependent protein kinase that phosphorylates transla-
ion initiation factor eIF2a, indirectly resulting in the in-
ibition of protein synthesis (Roberts et al., 1976; Lebleu
t al., 1976; Zilberstein et al., 1976; Meurs et al., 1990). Mx
roteins are IFN-induced GTPases in the dynamin su-
erfamily that interfere with the replication of some neg-
tive-stranded RNA viruses (Arnheiter et al., 1996).
Previously, mice were generated with homozygous
isruptions in the genes encoding either RNase L or PKR
Zhou et al., 1997; Yang et al., 1995). Because RNase L
ediates the biological effects of 2-5A, its absence pro-
uced a functional knockout of the 2-5A system. Un-
reated and IFN-treated RNase L2/2 mice died more
apidly in response to encephalomyocarditis virus
1 To whom reprint requests should be addressed at NB-40. Fax: (216)
M45-6269. E-mail: silverr@ccf.org.
435EMCV) infections than did identically treated wild-type,
arental mice. Nevertheless, there was a substantial
esidual anti-EMCV effect of IFN in RNase L2/2 mice. In
ddition, RNase L2/2 cells were defective in several ap-
ptotic pathways (Zhou et al., 1997). PKR2/2 mice showed
reduced anti-EMCV effect to IFNg and dsRNA (Yang et
l., 1995). Moreover, PKR2/2 cells were deficient in signal
ransduction to transcription factors nuclear factor-kB
nd IRF-1 and in stress-induced apoptosis (Yang et al.,
995; Kumar et al., 1997; Der et al., 1997). These studies
uggest that both the 2-5A/RNase L and PKR pathways
ontribute to apoptosis and provide some protection
gainst picornaviruses. Most laboratory strains of mice
ack a functional Mx protein due to naturally occurring
utations that render them susceptible to influenza vi-
us, whereas Mx11 mice and Mx1-expressing cells are
esistant to influenza virus (Arnheiter et al., 1996; Staeheli
t al., 1986, 1988). Here, we searched for the existence of
lternative pathways of IFN action by generating mice
hat lacked all three antiviral proteins. Residual antiviral
ffects of IFN in mice and cells defective in these path-
ay demonstrates the relative roles of characterized and
et-to-be discovered pathways of IFN action.
RESULTS
enerating mice deficient in three antiviral pathways
f IFN action
To generate mice defective in the antiviral pathways of
FN, RNase L2/2, and PKR2/2 mice were crossed on anx1-minus background, resulting in F1 heterozygous
0042-6822/99 $30.00
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436 ZHOU ET AL.ffspring (Zhou et al., 1997; Yang et al., 1995). An inter-
ross of the F1 heterozygous mice led to F2 offspring
ith homozygous disruptions of both the PKR and RNase
genes as determined by PCR and Southern blot as-
ays, respectively, from tail DNAs (see Materials and
ethods) (Figs. 1A and 1B). From seven litters of F2
ice, a total of 63 mice, 4 mice were identified as double
nockouts, a ratio consistent with the expected ratio of
:16 (a representative assay from a double knockout
ouse is shown in Figs. 1A and 1B, lane 3). The single-
nd double-knockout mice appeared normal and healthy.
To monitor the expression of Mx1, RNase L, and PKR,
rotein levels were measured in primary embryonic fibro-
last (EF) cells (see Materials and Methods) (Fig. 2). The
ack of Mx1 protein was demonstrated in the control and
ouble-knockout mice using Western (Fig. 2A) and South-
rn (data not shown) blots. Although Mx1 is present and
FN inducible in A2G cells and in 3T3 cells stably trans-
ected with an Mx1 cDNA, it is absent in the untreated and
FN-treated wild-type (control) EF cells and [PKR2/2 RNase
2/2] EF cells (Fig. 2A, lanes 6–9) (Staeheli et al., 1986).
herefore, the control and double-knockout mice lacked the
unctional Mx gene, Mx1. The [PKR2/2 RNase L2/2] mice are
hus referred to as triply deficient (TD) because they lack
x1, PKR, and RNase L. The absence of RNase L and PKR
roteins was verified by assays on extracts of EF cell lines
erived from the mice. RNase L, assayed by covalent cross-
inking to a 32P-labeled and bromine-substituted 2-5A ana-
og under ultraviolet light (Nolan-Sorden et al., 1990), was
resent and IFN inducible in control EFs, PKR2/2 EFs, and
929 cells and absent in the RNase L2/2 and TD EFs (Fig.
B). The PKR null cells had very low levels of RNase L
lanes 5 and 6). Western blots probed with a polyclonal
ntibody against murine PKR (Fig. 2C) showed PKR was
learly present and inducible by IFN treatment in control
Fs, RNase L2/2 EFs, and L929 cells but was absent in
KR2/2 and TD EFs. For comparison, levels of the 46/43-
Da forms of 2-5A synthetase were monitored with a rat
onoclonal antibody (Sokawa et al., 1994) and shown to be
resent and induced by IFN treatment in every EF cell type
nd in L929 cells (Fig. 2D). Interestingly, 2-5A synthetase
FIG. 1. Genetic analysis of RNase L2/2, PKR2/2, and Mx12/2 mice. (A)
CR analysis of wild-type and mutant PKR gene (Pkr). (B) Southern blot
nalysis of wild-type and mutant RNase L alleles.as induced to much higher levels in the TD cells than in Che other EF cells, suggesting that PKR and RNase L neg-
tively regulate the levels of this IFN-induced protein. Also
or comparison, actin levels were shown to be relatively
nvariant during these experiments (Figs. 2C and 2D).
he IFN antiviral state is reduced in mice lacking
Nase L, PKR, and Mx1
To establish the relative contributions of these pathways
o the anti-EMCV activity of IFN, mice were inoculated with
00 plaque-forming units (PFU) of EMCV by the intraperito-
eal (i.p.) route (see Materials and Methods) (Fig. 3). In the
bsence of IFN treatment, EMCV infections resulted in
eath of all of the control mice by 10 days (Fig. 3A). In
ontrast, the EMCV-infected TD mice were dead by 6 days
ostinfection (p.i.), indicating an increased susceptibility to
MCV compared with the control mice. The impact of IFN
n survival was determined by i.p. injections with different
oses of recombinant, hybrid human IFNa BDBB, which is
ffective in mice (Gangemi et al., 1989), 1 day before infec-
ions. At a dose of 104 units of IFN, survival of the TD mice
as extended by 2 days [i.e., 8 days were required before
ll of the mice died (Fig. 3B)]. Seventy-five percent of the
ontrol mice treated with 104 units of IFN died by 9 days
fter infection, whereas the remaining mice survived for an
dditional 5–7 days (Fig. 3B). Treatment with 5 3 104 units
f IFN substantially extended the survival time of both TD
nd control mice, although all of the TD mice were dead by
FIG. 2. Measurement of IFN-regulated protein levels in embryonic
ibroblasts from deficient and wild-type mice. (A) Determination of Mx1
rotein levels in whole-cell extracts in a Western blot probed with rabbit
olyclonal antibody to Mx1. (B) RNase L levels in cell extracts were
etermined by covalent cross-linking to a bromine-substituted, 32P-
abeled 2-5A analog. PKR (C), 2-5A synthetase (D), and actin (C and D)
evels in cell extracts from Western blots probed with antibodies.ontrol, wild-type cells; TD, triply deficient cells.
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437INTERFERON ACTION IN MICE LACKING PKR, RNase L, AND Mx15 days p.i. and half of the control mice were still alive at
his time (Fig. 3C). At the highest dose of IFN tested, 2.5 3
05 units, 33% of the TD mice and 88% of the control mice
ere still alive at 25 days p.i. (Fig. 3D). Therefore, there was
reduced antiviral effect of IFN in the TD mice compared
ith the control mice.
To determine the individual contributions of the 2-5A/
Nase L and PKR pathways to the anti-EMCV effect of
FN, survival was monitored in the mice lacking either
Nase L or PKR (Figs. 3E and 3F, respectively). A rela-
ively low dose of IFN (104 units) was used to differentiate
he effects of single and double knockout on survival. All
f the untreated, EMCV-infected RNase L2/2 and PKR2/2
FIG. 3. Survival of untreated and IFN-treated mice after EMCV infecti
ild-type mice.ice died by 8 and 9 days p.i., respectively. After IFN dreatment (104 units) and EMCV infection, the RNase L2/2
nd PKR2/2 mice died by 11 and 12 days p.i., respectively.
urvival times after EMCV infection in the single-knock-
ut mice was thus intermediate between those of control
nd TD mice (compare Figs. 3A and 3B with Figs. 3E and
F). These results suggest that PKR and the 2-5A system
roduce a similar level of anti-EMCV activity in mice.
esidual IFN activity against EMCV and vesicular
tomatitis virus in cultured fibroblasts lacking
ifferent antiviral proteins
Because the antiviral response in the mice could be
e IFN doses are indicated. There were 8 or 9 mice per group. Control,ons. Thue to a combination of innate and adaptive immunity,
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438 ZHOU ET AL.iral infections of primary EF cells were performed to
ifferentiate between these possibilities (see Materials
nd Methods). Cells were incubated in the absence or
resence of different doses of IFN for 22 h before infec-
ion with EMCV at a multiplicity of infection (m.o.i.) of 0.01
FU/cell (Fig. 4). A typical IFN dose-response curve was
enerated in the control cells with more than 4 log10 units
f inhibition of viral replication at the highest dose of IFN
105 units/ml). Surprisingly, a nearly identical IFN dose-
esponse curve was generated with the RNase L2/2
ells. These results are consistent with a relatively weak,
neffectual 2-5A system in wild-type EF cells indicated by
ow levels of RNase L and 2-5A-synthetase (Figs. 2B and
D). In contrast, the anti-EMCV effect of IFN was reduced
n the PKR2/2 and TD cells (Fig. 4).
Previous reports suggested that the rhabdovirus ve-
icular stomatitis virus (VSV) is resistant to the antiviral
ffects of RNase L, PKR, and Mx1 (Arnheiter et al., 1996;
ilverman and Cirino, 1997). To perform a more definitive
nalysis of the possible contributions of these pathways
o the anti-VSV effect of IFN, cells were infected at an
.o.i. of 0.1 in the presence or absence of prior IFN
reatment (Fig. 5). At the highest doses of IFN, more than
log10 units of inhibition was observed in the control and
Nase L2/2 cells. At a low dose of IFN treatment, 30
nits/ml, there was sixfold less inhibition of VSV in the
Nase L2/2 cells compared with the control cells. Fur-
hermore, the anti-VSV effect of IFN at 30 or 300 units/ml
as substantially reduced, by 50- to 100-fold, in the
KR2/2 and TD cells. These data demonstrate that PKR is
argely responsible for the difference in the anti-VSV
ffect of IFN observed between wild-type and TD cells.
DISCUSSION
We present clear evidence for the existence of alter-
FIG. 4. Anti-EMCV effect of IFN in embryonic fibroblast lacking
Nase L, PKR, and Mx1. Cells were treated with different doses of IFNa
nd subsequently infected with EMCV (Materials and Methods). Viral
iters were determined on indicator cells.ative antiviral pathways beyond the 2-5A, PKR, and Mx dystems. These data were obtained by an analysis of
ice deficient in all three pathways. The IFN system is
undamental to the survival of higher vertebrate animals
ecause it provides a broad, early defense system
gainst diverse types of pathogens. It is not surprising,
herefore, that IFNs regulate a large number of genes
Der et al., 1998). ISGs such as the 2-5A synthetases,
KR, and the Mx proteins are likely to perform at least
artially overlapping functions in IFN action. The 2-5A/
Nase L and PKR pathways respond to dsRNA produced
uring the course of viral infections to trigger antiviral
esponses in cells that degrades RNA and inhibits pro-
ein synthesis initiation, respectively. In contrast, Mx pro-
eins interfere with replicative cycles of some negative-
trand RNA viruses by interfering with the intracellular
ovement and functions of viral proteins (Stark et al.,
998). Although these three pathways have been firmly
stablished to suppress viral replication in IFN-treated
ells, redundancy in the IFN system is apparent even
hen examining a single type of virus (Figs. 3 and 4). The
isruption of either PKR or RNase L causes mice to die
ore rapidly after EMCV infections, whereas a combina-
ion knockout of both genes causes an additive defi-
iency in susceptibility to EMCV (Fig. 3). Nevertheless,
here is a substantial residual anti-EMCV effect of IFN in
he TD mice. Therefore, although the 2-5A/RNase L and
KR pathways contribute to the anti-EMCV effect of IFN,
lternative pathways are present and active in virus-
nfected mice. Mx1-expressing cells are susceptible to
icornavirus infections (Pavlovic and Staeheli, 1991), and
herefore Mx1 probably does not contribute to the anti-
MCV effect of IFN. In contrast, there is a plethora of
vidence showing the anti-EMCV effects of the 2-5A and
KR pathways (Silverman and Cirino, 1996).
Previously, using postcrisis RNase L2/2 EF cell lines
nstead of primary EF cells, there was a small reduction
n the anti-EMCV effect of IFN (Zhou et al., 1997). The
FIG. 5. Effect of IFN against VSV in cells lacking RNase L, PKR, and
x1. The effect of pretreatments of embryonic fibroblasts with differentoses of IFNa on VSV yields is shown.
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439INTERFERON ACTION IN MICE LACKING PKR, RNase L, AND Mx1ikely reasons for the lack of a 2-5A system effect in
FN-treated control EF cells are the very low levels of
Nase L and 2-5A synthetase (Fig. 2B and 2D, compare
anes 8 and 10). In other words, the wild-type EF cells
hat were used for comparison possess a weak 2-5A
ystem. Clearly, however, the 2-5A system provides an
nti-EMCV effect in the whole-animal model (Zhou et al.,
997 and Fig. 3E of this study). In contrast, the anti-EMCV
ffect of IFN was greatly reduced in the PKR2/2 and TD
ell lines. For instance, at the highest level of IFN tested
he antiviral activity was reduced by 50- and 200-fold in
he TD and PKR2/2 cells, respectively. Nevertheless,
here was a substantial, residual anti-EMCV IFN effect of
0- to 500-fold in the PKR2/2 and TD cells (Fig. 4). In
ontrast to some previous reports, the RNase L and PKR
athways are shown here to play a role in the antiviral
ctivity of IFN against VSV. Nevertheless, there was a
ubstantial residual anti-VSV effect of IFN in RNase L2/2,
KR2/2, and TD cells.
Our results provide the first conclusive evidence for
he existence of novel pathways of IFN action against
hese viruses. Multiple, unique, as well as redundant,
athways likely evolved to deal with the diversity and
omplexity of the virus world and to overcome viral strat-
gies for neutralizing host defenses (Stark et al., 1998).
ethal viral infections present effective and powerful
elective pressures on populations of organisms. During
iral epidemics, survival may depend on the presence of
particular ISG. Similarly, host proteins that provide
artial or incomplete immunity evolve to provide greater
rotection to the host. Determination of the relative con-
ributions of the various pathways of IFN action will be a
hallenge due to the large number of IFN-regulated
enes (Der et al., 1998). However, only by understanding
he specific functions of the proteins encoded in the ISGs
ill the biological effects of IFNs be understood. In this
egard, the TD mice represent a unique model system for
nvestigating alternative modes of IFN action.
MATERIALS AND METHODS
eneration of RNase L2/2, and PKR2/2
ouble-knockout mice
RNase L2/2 and PKR2/2 mice were crossbred, and tail
NA from the offspring was analyzed in Southern blots to
etermine RNase L genotype as described previously
Zhou et al., 1997) and by PCR to determine the PKR
enotype using a common upstream primer, PC1 (59-
TTTGGCTATTTCTCTGTGTTCATTGGA-39) paired either
ith PKR-X2 (59-GTAATGGCTACTCCGTGCATCTGGGC-
9) to detect the wild-type PKR allele or with NEO-P3
59-ATTCGCAGCGCATCGCCTTCTATCGCC-39) to detect
he targeted PKR mutant allele. The F1 heterozygous
ice were intercrossed to obtain RNase L2/2 and PKR2/2ouble-knockout mice. tetection of Mx1, RNase L, PKR, and 2-5A synthetase
43 kDa)
Analysis of IFN induction of proteins was performed
fter treatment of the cells with 2000 units/ml IFNa for
8 h. The amounts of cell extracts were 200 mg protein/
ane (in Fig. 2). Rabbit polyclonal antibody to Mx1 at
:500, polyclonal anti-murine PKR antibody raised in
KR2/2 mice at 1:500, rat monoclonal anti-43 kDa 2-5A
ynthetase (68-10) antibody (Sokawa et al., 1994) at 1:500,
nd anti-actin antibody (Boehringer Mannheim) at 1:6000
ere used. Primary antibodies were detected using anti-
ouse IgG-horseradish peroxidase or anti-rabbit IgG-
orseradish peroxidase (GIBCO BRL) at 1:5000 with en-
anced chemiluminescence (ECL; Amersham). RNase L
as detected by UV covalent crosslinking to a 32P-la-
eled, bromine-substituted 2-5A analog followed by
DS/polyacrylamide gel electrophoresis and autoradiog-
aphy (Nolan-Sorden et al., 1990).
ell culture
Primary EF cell cultures were established from 16-day
ostcoitus embryos as described previously (Zhou et al.,
997). Briefly, embryos were removed under sterile con-
itions to PBS in tissue culture dishes and then minced.
he tissue was incubated with 0.05% trypsin and 0.53
M EDTA at 4°C for 16 h to dissociate the cells. Excess
rypsin solution was removed, and the tissue was incu-
ated for a further 30 min at 37°C. Two volumes of
MEM containing 10% FBS was added, and the cells
ere then vigorously pipetted. Cells were cultured in
resh DMEM with 10% FBS. Early-passage (three or four),
rimary EF cells were grown in DMEM–10% FBS–peni-
illin/streptomycin.
ssays for the antiviral activity of interferon
n primary cells
Hybrid recombinant human interferon-a BDBB (a gift
rom H.-K. Hochkeppel, Novartis Pharma AG) (Gangemi
t al., 1989), active on both human and murine cells, was
sed in all experiments involving added interferon. The
MCV, M variant, was obtained from American Type
ulture Collection (catalog number VR-1314) whereas the
SV, New Jersey strain, was a gift from Amiya Banerjee
Cleveland Clinic).
Cells (105 cells/well on 6-well plates) were treated with
ifferent amounts of IFNa (BDBB) for 22 h as indicated in
he figures and text. Medium was aspirated, and 1 ml of
he virus stocks in DMEM containing 2% FBS was added
o each well. After 1 h of infection, virus was aspirated,
nd fresh medium containing 10% FBS was added. Cells
ere incubated overnight, and the virus in the media was
ollected and centrifuged, and supernatants were stored
t 270°C. Virus was subjected to fourfold serial dilu-ions, with six replicates per dilution, on L929 cells on
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440 ZHOU ET AL.6-well plates. Cytopathic effects were recorded visually
y observing the cells in each well under a microscope.
ach data point in Figs. 4 and 5 was an average of the
iters obtained from two pools of six separate infections
i.e., 12 replicates per data point). TCID50 values were
alculated as described previously (Johnson and Bying-
on, 1990).
ouse survival assays
Six-week-old mice, either untreated or injected i.p.
ith different doses of human recombinant IFNa (BDBB)
Gangemi et al., 1989) 20 h prior to infections, were
njected i.p. with 100 PFU of EMCV and monitored daily
or survival.
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